TABLE 1.
Physician characteristics by country
| Characteristic | Total N = 378 | UK n = 76 | France n = 75 | Germany n = 76 | Italy n = 76 | Spain n = 75 |
|---|---|---|---|---|---|---|
| Age, n (%), years | ||||||
| <35 |
28 (7.4) |
5 (6.6) |
3 (4.0) |
1 (1.3) |
18 (23.7) |
1 (1.3) |
| 35–44 |
138 (36.5) |
32 (42.1) |
23 (30.7) |
24 (31.6) |
26 (34.2) |
33 (44.0) |
| 45–54 |
156 (41.3) |
33 (43.4) |
35 (46.7) |
35 (46.1) |
25 (32.9) |
28 (37.3) |
| 55–64 |
55 (14.6) |
6 (7.9) |
13 (17.3) |
16 (21.1) |
7 (9.2) |
13 (17.3) |
| ≥65 |
1 (0.3) |
0 (0.0) |
1 (1.3) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
| Gender, n (%) | ||||||
| Male |
243 (64.3) |
49 (64.5) |
54 (72.0) |
63 (82.9) |
35 (46.1) |
42 (56.0) |
| Female |
135 (35.7) |
27 (35.5) |
21 (28.0) |
13 (17.1) |
41 (53.9) |
33 (44.0) |
| Years in practice, mean (SE) |
14.70 (0.32) |
13.05 (0.59) |
16.75 (0.70) |
14.46 (0.64) |
13.29 (0.69) |
16.00 (0.75) |
| % Professional time spent in direct patient care, mean (SE) |
88.72 (0.36) |
87.70 (0.73) |
89.64 (0.80) |
88.28 (0.78) |
89.66 (0.87) |
88.35 (0.83) |
| No. of MDS patients seen and/or treated in past 3 months, mean (SE) |
54.47 (2.26) |
41.53 (3.71) |
59.68 (5.43) |
55.97 (5.26) |
63.14 (5.10) |
52.08 (5.38) |
| MDS classification categories used by physicians, n (%) | ||||||
| IPSS |
158 (41.8) |
39 (51.3) |
40 (53.3) |
30 (39.5) |
32 (42.1) |
17 (22.7) |
| IPSS‐R |
220 (58.2) |
37 (48.7) |
35 (46.7) |
46 (60.5) |
44 (57.9) |
58 (77.3) |
| % TD patients, mean (SE) |
47.41 (1.02) |
46.84 (2.35) |
45.04 (2.18) |
50.67 (2.55) |
47.95 (2.20) |
46.52 (2.06) |
| Practice locations, n (%) | ||||||
| Urban |
334 (88.4) |
56 (73.7) |
69 (92.0) |
68 (89.5) |
72 (94.7) |
69 (92.0) |
| Suburban |
39 (10.3) |
20 (26.3) |
6 (8.0) |
5 (6.6) |
4 (5.3) |
4 (5.3) |
| Rural |
5 (1.3) |
0 (0.0) |
0 (0.0) |
3 (3.9) |
0 (0.0) |
2 (2.7) |
| No. of oncologists/hematologists in the practice, n (%) | ||||||
| 1 |
6 (1.6) |
0 (0.0) |
0 (0.0) |
6 (7.9) |
0 (0.0) |
0 (0.0) |
| 2–4 |
107 (28.3) |
20 (26.3) |
18 (24.0) |
46 (60.5) |
13 (17.1) |
10 (13.3) |
| 5–10 |
116 (30.7) |
26 (34.2) |
30 (40.0) |
12 (15.8) |
22 (28.9) |
26 (34.7) |
| >10 |
149 (39.4) |
30 (39.5) |
27 (36.0) |
12 (15.8) |
41 (53.9) |
39 (52.0) |
Abbreviations: IPSS‐R, revised International Prognostic Scoring System; MDS, myelodysplastic syndromes; SE, standard error; TD, transfusion dependent.